Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value
$503.92M
Total Bought
$891.4K
Total Sold
$26.29M
Net Transaction
-$25.40M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Nanobiotix S.A.(NBTX)5,623,8165,623,816025,455106,23421.08%+80,779
Protagonist Therapeutics Inc.2,449,1832,449,1830136,395162,69932.29%+26,304
Rapport Therapeutics, Inc.(RAPP)2,498,0511,784,517-713,53428,55353,00010.52%+24,447
Contineum Therapeutics Inc.(CTNM)1,979,1731,979,17308,13423,2554.61%+15,121
MeiraGTx Holdings plc(MGTX)6,641,0646,641,064043,89754,65610.85%+10,759
CVRx, Inc.(CVRX)4,103,4304,103,430023,88233,1156.57%+9,233
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,59803,9818,5401.69%+4,558
Xencor, Inc.(XNCR)748,062748,06206,0898,7751.74%+2,686
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,44501,4003,3660.67%+1,966
Vor Biopharma, Inc.(VOR)1,074,65853,732-1,020,9261,1392,6180.52%+1,479
Lyell Immunopharma Inc.(LYEL)054,887+54,88708910.18%+891
Fate Therapeutics, Inc.(FATE)3,379,0643,379,06403,5144,2580.84%+743
Rallybio Corporation(RLYB)3,636,3633,636,36301,2091,8150.36%+605
Adicet Bio, Inc.364,472364,47202282950.06%+67
Standard BioTools Inc(LAB)311,967311,96703714060.08%+34
BiomX Inc.(PHGE)96,86696,866043510.01%+8
Senseonics Holdings, Inc.(SENS)54,62154,621027240.00%-3
Nano-X Imaging Ltd.
ORD SHS
158,852158,85208315880.12%-243
Lyell Immunopharma Inc.(LYEL)41,1650-41,1653680—-368
Legend Biotech Corporation(LEGN)814,586814,586028,20926,5645.27%-1,645
Procept BioRobotics Corporation(PRCT)357,939357,939020,37012,7752.54%-7,595
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q3 2025 | TickerTrail